Advanced search
Publication Cover
Current Medical Research and Opinion Volume 26, 2010 - Issue 2
Submit an article Journal homepage
251
Views
24
CrossRef citations to date
0
Altmetric
Original Article

Acute epilepsy exacerbations in patients switched between A-rated anti-epileptic drugs

Scott T. Devine Express-Scripts, Inc., St Louis, MO, USACorrespondence[email protected]
,
Edmond Weisbart Express-Scripts, Inc., St Louis, MO, USA
,
John Barron HealthCore, Inc., Wilmington, DE, USA
&
Andrew Behm Express-Scripts, Inc., Bloomington, MN, USA
Pages 455-463 | Accepted 16 Nov 2009, Published online: 17 Dec 2009

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Josemir W Sander, Philippe Ryvlin, Hermann Stefan, Daniel R Booth & Jürgen Bauer. (2010) Generic substitution of antiepileptic drugs. Expert Review of Neurotherapeutics 10:12, pages 1887-1898.
Read now

Articles from other publishers (23)

Taoufik Alsaadi, Abubaker Almadani, Jasem Al-Hashel, Abdullah Al Salti, Gayane Melikyan & Riaz Ahmed Khan. (2023) Commentary: Consensus Guidelines on the Appropriate Use of Brand-Name and Generic Anti-Seizure Medication for the Management of Epilepsy in the Gulf Region. Neurology and Therapy 12:4, pages 1015-1031.
Crossref
Patrik Olsson, Kevin Pearson, Arne Reimers & Kristina Källén. (2021) Widespread skeptic attitudes among people with epilepsy toward generic antiseizure drugs – A Swedish survey study. Epilepsy & Behavior 114, pages 107554.
Crossref
Johanna Weitzel, Susanne Erzkamp, Klaus Langer & Olaf Rose. (2020) Effects of generic exchange of solid oral dosage forms in neurological disorders: a systematic review. International Journal of Clinical Pharmacy 42:2, pages 393-417.
Crossref
Valeria Belleudi, Francesco Trotta, Simona Vecchi, Laura Amato, Antonio Addis & Marina Davoli. (2018) Studies on drug switchability showed heterogeneity in methodological approaches: a scoping review. Journal of Clinical Epidemiology 101, pages 5-16.
Crossref
Patrick Kwan & André Palmini. (2017) Association between switching antiepileptic drug products and healthcare utilization: A systematic review. Epilepsy & Behavior 73, pages 166-172.
Crossref
Aaron S. KesselheimKatsiaryna BykovJoshua J. GagneShirley V. WangNiteesh K. Choudhry. (2016) Switching generic antiepileptic drug manufacturer not linked to seizures. Neurology 87:17, pages 1796-1801.
Crossref
Joshua J. Gagne, Aaron S. Kesselheim, Niteesh K. Choudhry, Jennifer M. Polinski, David Hutchins, Olga S. Matlin, Troyen A. Brennan, Jerry Avorn & William H. Shrank. (2015) Comparative effectiveness of generic versus brand-name antiepileptic medications. Epilepsy & Behavior 52, pages 14-18.
Crossref
Elisabeth Polard, Emmanuel Nowak, André Happe, Arnaud Biraben & Emmanuel Oger. (2015) Brand name to generic substitution of antiepileptic drugs does not lead to seizure-related hospitalization: a population-based case-crossover study. Pharmacoepidemiology and Drug Safety 24:11, pages 1161-1169.
Crossref
Natalia Shcherbakova, Karen Rascati, Carolyn Brown, Kenneth Lawson, Suzanne Novak, Kristin M. Richards & Linda Yoder. (2014) Factors Associated with Seizure Recurrence in Epilepsy Patients Treated with Antiepileptic Monotherapy: A Retrospective Observational Cohort Study using US Administrative Insurance Claims. CNS Drugs 28:11, pages 1047-1058.
Crossref
Ryan N. Hansen, Hiep P. Nguyen & Sean D. Sullivan. (2013) Bioequivalent antiepileptic drug switching and the risk of seizure-related events. Epilepsy Research 106:1-2, pages 237-243.
Crossref
Maren Carbon & Christoph U. Correll. (2013) Rational Use of Generic Psychotropic Drugs. CNS Drugs 27:5, pages 353-365.
Crossref
Taliser R. Avery, Martin Kulldorff, Yury Vilk, Lingling Li, T. Craig Cheetham, Sascha Dublin, Robert L. Davis, Liyan Liu, Lisa Herrinton & Jeffrey S. Brown. (2013) Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrual. Pharmacoepidemiology and Drug Safety 22:5, pages 488-495.
Crossref
Michael Privitera. (2013) Generic substitution of antiepileptic drugs. Neurology Clinical Practice 3:2, pages 161-164.
Crossref
Jennifer Meyer, David Fardo, Steven T. Fleming, Claudia Hopenhayn, Yevgeniya Gokun & Melody Ryan. (2013) Generic antiepileptic drug prescribing: A cross-sectional study. Epilepsy & Behavior 26:1, pages 1-6.
Crossref
Jason Noel. (2012) A high-stakes decision: Generic substitution of antiepileptic drugs. Mental Health Clinician 2:5, pages 119-120.
Crossref
Daniel M. Hartung, Luke Middleton, Leanne Svoboda & Jessina C. McGregor. (2012) Generic Substitution of Lamotrigine Among Medicaid Patients with Diverse Indications. CNS Drugs 26:8, pages 707-716.
Crossref
I. G. Rudakova, A. S. Kotov & Yu. A. Belova. (2012) Use of Generic Medicines in the Treatment of Epilepsy Using Topiramate as an Example. Neuroscience and Behavioral Physiology 42:6, pages 550-555.
Crossref
Ripple Talati, Jennifer M. Scholle, Olivia P. Phung, Erika L. Baker, William L. Baker, Ajibade Ashaye, Jeffrey Kluger, Craig I. Coleman & C. Michael White. (2012) Efficacy and Safety of Innovator versus Generic Drugs in Patients with Epilepsy: A Systematic Review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 32:4, pages 314-322.
Crossref
Sara C. Erickson, Lisa Le, Scott D. Ramsey, Brian K. Solow, Armen Zakharyan, Karen M. Stockl, Ann S.M. Harada & Bradford Curtis. (2011) Clinical and pharmacy utilization outcomes with brand to generic antiepileptic switches in patients with epilepsy. Epilepsia 52:7, pages 1365-1371.
Crossref
. (2011) Generic antiepileptic drugs and associated medical resource utilization in the United States. Neurology 76:6, pages 583-584.
Crossref
J J Gagne, J Avorn, W H Shrank & S Schneeweiss. (2010) Refilling and Switching of Antiepileptic Drugs and Seizure-Related Events. Clinical Pharmacology & Therapeutics 88:3, pages 347-353.
Crossref
Sandra L. Helmers, Pierre Emmanuel Paradis, Ranjani Manjunath, Mei Sheng Duh, Marie-Hélène Lafeuille, Dominick Latrémouille-Viau, Patrick Lefebvre & David M. Labiner. (2010) Economic burden associated with the use of generic antiepileptic drugs in the United States. Epilepsy & Behavior 18:4, pages 437-444.
Crossref
Robert H. Howland. (2010) Are Generic Medications Safe and Effective?. Journal of Psychosocial Nursing and Mental Health Services 48:3, pages 13-16.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.